Home/Filings/4/0001209191-14-045982
4//SEC Filing

SALIX PHARMACEUTICALS LTD 4

Accession 0001209191-14-045982

CIK 0001009356operating

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 4:24 PM ET

Size

6.8 KB

Accession

0001209191-14-045982

Insider Transaction Report

Form 4
Period: 2014-07-01
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    2014-07-01$123.35/sh8,253$1,018,008613,154.2 total
Holdings
  • Common Stock

    (indirect: By GRAT)
    400,000
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (44,000 underlying)
    44,000
Footnotes (2)
  • [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
  • [F2]Options are 100% vested.

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001009356

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:24 PM ET
Size
6.8 KB